Chronic granulomatous disease: quantitative clinicopathological relationships.
D000293:Adolescent; D000740:Anemia / Q000150:complications; D001168:Arthritis / Q000150:complications; D001798:Blood Proteins; D001827:Body Height; D001835:Body Weight; D002066:Busulfan / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006099:Granuloma / Q000188:drug therapy / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D006579:Heterozygote; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D007239:Infections; D007962:Leukocytes / Q000032:analysis; D007964:Leukocytosis / Q000150:complications; D008199:Lymphadenitis; D008206:Lymphatic Diseases / Q000473:pathology; D008297:Male; D008722:Methods; D012871:Skin Diseases / Q000150:complications; D013194:Staining and Labeling; D013778:Tetrazolium Salts; D005719:gamma-Globulins / Q000032:analysis
D001798:Blood Proteins; D013778:Tetrazolium Salts; D005719:gamma-Globulins; D002066:Busulfan